These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11201042)

  • 1. Osteoprotegerin and osteoclast differentiation factor in tooth eruption.
    Wise GE; Lumpkin SJ; Huang H; Zhang Q
    J Dent Res; 2000 Dec; 79(12):1937-42. PubMed ID: 11201042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption.
    Wise GE; Yao S; Zhang Q; Ren Y
    Arch Oral Biol; 2002 Mar; 47(3):247-54. PubMed ID: 11839361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle.
    Liu D; Yao S; Wise GE
    Eur J Oral Sci; 2006 Feb; 114(1):42-9. PubMed ID: 16460340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injections of osteoprotegerin and PMA delay tooth eruption.
    Wise GE; Yao S; Liu D
    Clin Anat; 2006 Jan; 19(1):19-24. PubMed ID: 16283633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF-1 regulation of osteoclastogenesis for tooth eruption.
    Wise GE; Yao S; Odgren PR; Pan F
    J Dent Res; 2005 Sep; 84(9):837-41. PubMed ID: 16109994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption.
    Heinrich J; Bsoul S; Barnes J; Woodruff K; Abboud S
    Arch Oral Biol; 2005 Oct; 50(10):897-908. PubMed ID: 16137499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronology and regulation of gene expression of RANKL in the rat dental follicle.
    Liu D; Yao S; Pan F; Wise GE
    Eur J Oral Sci; 2005 Oct; 113(5):404-9. PubMed ID: 16202028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
    Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
    Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel molecular mechanism modulating osteoclast differentiation and function.
    Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Goto M; Mochizuki SI; Tsuda E; Morinaga T; Udagawa N; Takahashi N; Suda T; Higashio K
    Bone; 1999 Jul; 25(1):109-13. PubMed ID: 10423033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts.
    Tada T; Jimi E; Okamoto M; Ozeki S; Okabe K
    Int J Cancer; 2005 Aug; 116(2):253-62. PubMed ID: 15800904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway.
    Fukushima H; Jimi E; Kajiya H; Motokawa W; Okabe K
    J Dent Res; 2005 Apr; 84(4):329-34. PubMed ID: 15790738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
    Hofbauer LC; Khosla S; Dunstan CR; Lacey DL; Boyle WJ; Riggs BL
    J Bone Miner Res; 2000 Jan; 15(1):2-12. PubMed ID: 10646108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
    Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
    J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dental cells express factors that regulate bone resorption.
    Rani CS; MacDougall M
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):145-52. PubMed ID: 10860862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption.
    Kostenuik PJ; Shalhoub V
    Curr Pharm Des; 2001 May; 7(8):613-35. PubMed ID: 11375772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.